Neurology, American Board of Psychiatry and Neurology
Fibrosis, Inflammation, Multiple Sclerosis, Muscular Dystrophy
MD, Fudan University Shanghai Medical College
PhD, University of Cincinnati
Internship, Internal Medicine
Wayne State University
Wayne State University
Johns Hopkins Hospital
Chinese (Mandarin), Chinese (Shanghai), English
Roles of chemokines and chemokine receptors in Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is the most common, lethal, and currently untreatable genetic muscle disease. Muscle pathology of DMD is featured by chronic inflammation and fibrosis, which directly lead to muscle dysfunction and clinical muscle weakness. Ameliorating muscle inflammation and fibrosis may thus represent a viable therapeutic approach for DMD. The chemokine system plays a key role in recruiting inflammatory cells and profibrogenic cells into injured muscles. This research is to determine the roles of the chemokine system in inflammation and fibrosis associated with DMD and to explore the possibility of modifying inflammation, reducing fibrosis, and improving muscle function by altering the expression and function of related chemokines and chemokine receptors. The DMD mouse models and relevant chemokine or chemokine receptor knockout mouse models are being used for the study.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Zhou did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.